Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease

Author:

Kolarich Andrew1,George Thomas J.2,Hughes Steven J.3,Delitto Daniel3,Allegra Carmen J.2,Hall William A.4,Chang George J.56,Tan Sanda A.3,Shaw Christiana M.3,Iqbal Atif3ORCID

Affiliation:

1. University of Florida College of Medicine; Gainesville Florida

2. Division of Hematology and Oncology, Department of Medicine; University of Florida College of Medicine; Gainesville Florida

3. Department of Surgery; University of Florida College of Medicine; Gainesville Florida

4. Department of Radiation Oncology; Medical College of Wisconsin; Milwaukee Wisconsin

5. Department of Surgical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

6. Department of Health Services Research; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

National Institutes of Health Division of Loan Repayment (to Daniel Delitto)

American Cancer Society, and the National Cancer Institute

Medical College of Wisconsin

National Center for Research Resources

National Center for Advancing Translational Sciences

University of Texas MD Anderson Cancer Center

National Institutes of Health

Research support from Elekta A.B. to the Medical College of Wisconsin (WAH)

National Cancer Institute

American Cancer Society

National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health

National Institutes of Health Division of Loan Repayment (DD)

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3